Norges Bank Cullinan Oncology, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$9.05 - $11.72 $922,195 - $1.19 Million
-101,900 Closed
0 $0
Q4 2022

Feb 14, 2023
BUY
$9.72 - $13.62 $990,468 - $1.39 Million
101,900 New
101,900 $1.08 Million
Q3 2022

Nov 13, 2023
BUY
$11.82 - $15.42 $1.2 Million - $1.57 Million
101,900 New
101,900 $1.31 Million

Others Institutions Holding CGEM

# of Institutions
146
Shares Held
67.6M
Call Options Held
612K
Put Options Held
118K
View Full List

About Cullinan Oncology, Inc.

CGEM Quotes by TradingView
  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $499M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email